Frequently Asked Questions
The global DNA synthesis market was valued at USD 2748.9 Million in 2022.
The DNA synthesis market is expected to grow at a CAGR of 20.33% between 2023 and 2030, reaching USD 12082.3 Million in 2030.
Reagents and consumables are the leading segment by product type, holding over 40% share in value in 2022.
The therapeutics segment governs the global demand for DNA synthesis, holding a massive share of over 30% in 2022.
The RNA oligonucleotides segment will post the highest CAGR over the projection period.
With more than one-third of the market in 2022, North America is driving the expansion of the DNA synthesis industry.
The top players include Thermo Fisher Scientific Inc, Twist Bioscience, Bioneer Corporation, Eton Bioscience, LGC Biosearch Technologies, IBA GmbH, Eurofins Scientific, Integrated DNA Technologies Inc, Quintara Biosciences, GenScript Biotech Corporation, and Others.
Major market drivers of the DNA synthesis industry include advancements in gene editing technologies and the expanding applications in genomics and personalized medicine.
Major market restraints of the DNA synthesis industry encompass regulatory and ethical challenges, along with supply chain vulnerabilities.
Major market opportunities of the DNA synthesis industry lie in expanding applications in therapeutics and tapping into emerging markets while expanding the global footprint of DNA synthesis services and products.